02 Aug 2024 --- Even though South Africa’s Biotrade and Bioprospecting legislation aims to promote biodiversity and fair and equitable benefit-sharing with communities in raw materials’ sourcing areas, Parceval worries that the system’s rigidity may limit innovation and the use of natural resources. In addition, the South African-based distributor and manufacturer of herbal medicines and botanical extracts warns that the system inadvertently favors larger companies, who can deal with its elaborate requirements. In the last installment of our series on South Africa’s Biotrade and Bioprospecting regulation, Nutrition Insight examines how the country’s legal system affects companies and innovation with Ulrich Feiter, Parceval’s CEO, and Avril Harvey, its special projects manager.
